Eyad Elkord

12.5k total citations · 2 hit papers
126 papers, 7.7k citations indexed

About

Eyad Elkord is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Eyad Elkord has authored 126 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Immunology, 79 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Eyad Elkord's work include Cancer Immunotherapy and Biomarkers (62 papers), Immune Cell Function and Interaction (54 papers) and Immunotherapy and Immune Responses (29 papers). Eyad Elkord is often cited by papers focused on Cancer Immunotherapy and Biomarkers (62 papers), Immune Cell Function and Interaction (54 papers) and Immunotherapy and Immune Responses (29 papers). Eyad Elkord collaborates with scholars based in United Kingdom, Qatar and United Arab Emirates. Eyad Elkord's co-authors include Varun Sasidharan Nair, Salman M. Toor, Reem Saleh, Pramod Darvin, Belal Chaudhary, Appalaraju Jaggupilli, Basil J. Ammori, Yazan S. Khaled, Rowaida Z. Taha and Robert E. Hawkins and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Cancer Research.

In The Last Decade

Eyad Elkord

124 papers receiving 7.6k citations

Hit Papers

Immune checkpoint inhibitors: recent progress and potenti... 2018 2026 2020 2023 2018 2025 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immune checkpoint inhibitors: recent progress and potential biomarkers
    2018 1.5k citations Salman M. Toor, Varun Sasidharan Nair et al. profile →
  2. Resistance mechanisms to immune checkpoint inhibitors: updated insights
    2025 43 citations Bassam R. Ali, Eyad Elkord et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eyad Elkord United Kingdom 41 4.3k 3.9k 2.2k 1.1k 950 126 7.7k
Hua Liang China 29 4.1k 1.0× 4.1k 1.1× 2.2k 1.0× 1.2k 1.1× 626 0.7× 79 7.9k
Thomas F. Gajewski United States 23 5.4k 1.3× 6.0k 1.5× 2.8k 1.3× 1.1k 1.0× 1.0k 1.1× 33 9.4k
Miguel F. Sanmamed Spain 40 5.6k 1.3× 5.0k 1.3× 2.5k 1.1× 1.5k 1.4× 1.1k 1.2× 115 9.3k
Yuanyuan Zha United States 22 4.5k 1.0× 3.2k 0.8× 2.5k 1.1× 826 0.7× 462 0.5× 67 6.8k
Bernard A. Fox United States 48 4.4k 1.0× 4.4k 1.1× 2.2k 1.0× 560 0.5× 501 0.5× 200 7.6k
Jing Sun China 41 3.8k 0.9× 5.0k 1.3× 2.1k 0.9× 601 0.5× 951 1.0× 120 8.1k
Kristen E. Pauken United States 27 4.5k 1.1× 5.4k 1.4× 1.4k 0.6× 622 0.6× 476 0.5× 39 8.0k
Radek Špíšek Czechia 45 3.3k 0.8× 4.8k 1.3× 1.9k 0.8× 764 0.7× 464 0.5× 134 7.6k
Isabelle Cremer France 47 3.9k 0.9× 4.5k 1.2× 1.6k 0.7× 1.1k 1.0× 729 0.8× 89 7.4k
Tullia C. Bruno United States 42 4.2k 1.0× 4.4k 1.1× 1.6k 0.7× 1.0k 0.9× 748 0.8× 91 7.3k

Countries citing papers authored by Eyad Elkord

Since Specialization
Citations

This map shows the geographic impact of Eyad Elkord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyad Elkord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyad Elkord more than expected).

Fields of papers citing papers by Eyad Elkord

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyad Elkord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyad Elkord. The network helps show where Eyad Elkord may publish in the future.

Co-authorship network of co-authors of Eyad Elkord

This figure shows the co-authorship network connecting the top 25 collaborators of Eyad Elkord. A scholar is included among the top collaborators of Eyad Elkord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyad Elkord. Eyad Elkord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyiah, Abdo, Ahmed Al‐Harrasi, Najeeb Ur Rehman, & Eyad Elkord. (2025). Effect of boswellic acids on the expression of PD-1 and TIGIT immune checkpoints on activated human T cells. Fitoterapia. 181. 106401–106401.
2.
Ali, Bassam R., et al.. (2025). Resistance mechanisms to immune checkpoint inhibitors: updated insights. Molecular Cancer. 24(1). 20–20. 43 indexed citations breakdown →
3.
Meyiah, Abdo, Satya Kumar Avula, Ahmed Al‐Harrasi, & Eyad Elkord. (2024). Effects of 1H-1,2,3-Triazole Derivatives of 3-O-Acetyl-11-Keto-Beta-Boswellic Acid from Boswellia sacra Resin on T-Cell Proliferation and Activation. Pharmaceuticals. 17(12). 1650–1650. 1 indexed citations
4.
Elkord, Eyad. (2023). Abstract 6633: T regulatory cell subsets in colorectal cancer: friends or foes. Cancer Research. 83(7_Supplement). 6633–6633. 2 indexed citations
5.
Meyiah, Abdo, Murad Alahdal, & Eyad Elkord. (2023). Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers. iScience. 26(4). 106333–106333. 3 indexed citations
6.
7.
Murshed, Khaled, et al.. (2022). Associations of Complete Blood Count Parameters with Disease-Free Survival in Right- and Left-Sided Colorectal Cancer Patients. Journal of Personalized Medicine. 12(5). 816–816. 11 indexed citations
8.
Murshed, Khaled, et al.. (2022). Correlations between Circulating and Tumor-Infiltrating CD4+ T Cell Subsets with Immune Checkpoints in Colorectal Cancer. Vaccines. 10(4). 538–538. 5 indexed citations
9.
10.
11.
Shaath, Hibah, Salman M. Toor, Mohamed Abu Nada, Eyad Elkord, & Nehad M. Alajez. (2021). Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer. Scientific Reports. 11(1). 14456–14456. 11 indexed citations
12.
Toor, Salman M., Varun Sasidharan Nair, Reem Saleh, et al.. (2021). Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4+ T Cells Associated with Poor Disease-Specific Survival. Vaccines. 9(4). 334–334. 7 indexed citations
13.
Toor, Salman M., Varun Sasidharan Nair, Khaled Murshed, Mohamed Abu Nada, & Eyad Elkord. (2021). Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors. Vaccines. 9(1). 64–64. 17 indexed citations
14.
Toor, Salman M., Rowaida Z. Taha, Varun Sasidharan Nair, et al.. (2020). Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancer. Cancer Immunology Immunotherapy. 70(3). 803–815. 9 indexed citations
15.
Thomas, Remy, Hibah Shaath, Adviti Naik, et al.. (2020). Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy. Cancer Immunology Immunotherapy. 69(3). 449–463. 22 indexed citations
16.
Nair, Varun Sasidharan, Salman M. Toor, Rowaida Z. Taha, et al.. (2020). Transcriptomic Profiling of Tumor-Infiltrating CD4+TIM-3+ T Cells Reveals Their Suppressive, Exhausted, and Metastatic Characteristics in Colorectal Cancer Patients. Vaccines. 8(1). 71–71. 25 indexed citations
17.
Saleh, Reem, Salman M. Toor, & Eyad Elkord. (2020). Targeting TIM-3 in solid tumors: innovations in the preclinical and translational realm and therapeutic potential. Expert Opinion on Therapeutic Targets. 24(12). 1251–1262. 17 indexed citations
18.
Nair, Varun Sasidharan, Reem Saleh, Salman M. Toor, et al.. (2020). Epigenetic Regulation of Immune Checkpoints and T Cell Exhaustion Markers in Tumor-Infiltrating T Cells of Colorectal Cancer Patients. Epigenomics. 12(21). 1871–1882. 15 indexed citations
19.
Toor, Salman M., Raghvendra Mall, Ehsan Ullah, et al.. (2019). Investigation of the Effect of PD-L1 Blockade on Triple Negative Breast Cancer Cells Using Fourier Transform Infrared Spectroscopy. Vaccines. 7(3). 109–109. 13 indexed citations
20.
Vishnubalaji, Radhakrishnan, et al.. (2019). Integrated Transcriptome and Pathway Analyses Revealed Multiple Activated Pathways in Breast Cancer. Frontiers in Oncology. 9. 910–910. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hua Liang Breakdown of academic impact, for papers by Thomas F. Gajewski Breakdown of academic impact, for papers by Miguel F. Sanmamed Breakdown of academic impact, for papers by Yuanyuan Zha Breakdown of academic impact, for papers by Bernard A. Fox Breakdown of academic impact, for papers by Jing Sun Breakdown of academic impact, for papers by Kristen E. Pauken Breakdown of academic impact, for papers by Radek Špíšek Breakdown of academic impact, for papers by Isabelle Cremer Breakdown of academic impact, for papers by Tullia C. Bruno
Rankless by CCL
2026